Arturo Panduro Cerda

Dr. Panduro was born and raised in the iconic city of Tlaquepaque, Jalisco, Mexico, where he inherited the compassion for medicine and research. After graduating from the University of Guadalajara´s Medical School, he continued a specialty in Genetics. Later,  he was mentored by Dr. Marco Rojkind at CINVESTAV in Mexico City, where he obtained his Ph.D. degree. He continued postdoctoral training as an Associate Professor with Dr. David Shafritz at the Liver Research Center, Albert Einstein College of Medicine, New York City. In 2008, he completed a sabbatical year in viral hepatitis, working with Dr. Misashi Misokami at Nagoya University in Japan.  

Upon returning to Mexico City in 1985, he founded the Research Center in Molecular Hepatology at the Department of Gastroenterology, “Instituto Nacional de Ciencias Biomédicas y de la Nutrición, Salvador Zubirán.” In 1992, Dr. Panduro rejoined his Alma Mater as a full-time Professor, establishing the Ph.D. Program in Molecular Biology in Medicine and the Department of Genomic Medicine in Hepatology at the “Hospital Civil de Guadalajara, Fray Antonio Alcalde.”, the first research center of its kind in a Latin American public hospital.  

Dr. Panduro´s career focuses on teaching, research, and providing medical assistance in Genomic Medicine. The Genomic Medicine in Hepatology Program is dedicated to studying the major causes of liver disease among the Mexican population. One line of research is viral hepatitis B and C, studying the interactions between the host´s genes, viral genotypes, and environmental factors that influence the clinical outcome of infections. At the Nutrigenetic Clinic for Liver Disease, early detection strategies of liver damage due to obesity, NASH, or viral hepatitis are designed to prevent liver disease and improve quality of life. Dr. Panduro´s work includes 160 research articles, international books, and book chapters (h index of 36 and 10-index of 116), leading him to be distinguished as a Level III National Researcher. He has mentored more than 30 postdoctoral and Ph.D. students and has trained specialists in the field of Genomic Medicine, many of whom are today successful researchers and academic leaders.  

The EASL, the Japan Society of Hepatology, have awarded his work, and he is a Fellow member of the AASLD. As past Chair President of the Mexican Association of Hepatology, he was honored for his outstanding contributions in Genomic Medicine in Hepatology. Currently, he is Editor-in-Chief for Annals of Hepatology, which has been ranked Q2 in medicine and is considered the best journal of Hepatology in the Latin American region (IF 2.125)